Interaction between doxycycline and some antiepileptic drugs

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Drug Interactions

Background:

• Diphenylhydantoin (DPH) and carbamazepine (CBZ) are commonly prescribed antiepileptic drugs.
• These drugs are known to induce hepatic drug-metabolizing enzymes.
• The impact of these enzyme inducers on the pharmacokinetics of doxycycline is not fully understood.

Purpose of the Study:

• To investigate the effect of long-term diphenylhydantoin and/or carbamazepine treatment on the half-life of doxycycline.
• To determine if standard doxycycline doses maintain adequate bacteriostatic levels in patients taking these anticonvulsants.

Main Methods:

• A pharmacokinetic study was conducted involving four groups of patients.
• Group 1: Seven patients on long-term DPH treatment.
• Group 2: Five patients on long-term CBZ treatment.
• Group 3: Four patients on combined DPH and CBZ treatment.
• Group 4: Nine healthy control patients.
• Doxycycline half-life was measured in each patient after administration of a standard dose.

Main Results:

• The mean half-life of doxycycline was significantly shorter in patients on DPH (7.2 ± 0.4 hours), CBZ (8.4 ± 1.4 hours), or combined therapy (7.4 ± 0.7 hours) compared to controls (15.1 ± 1.0 hours).
• These reduced half-lives suggest that doxycycline may not achieve or maintain minimum inhibitory concentrations (MICs) for effective bacteriostasis at standard doses in these patient populations.
• The observed drug interaction is attributed to the enzyme-inducing properties of DPH and CBZ, leading to accelerated doxycycline metabolism.

Conclusions:

• Long-term treatment with diphenylhydantoin and carbamazepine significantly reduces the half-life of doxycycline.
• Standard doxycycline dosages may be insufficient to achieve therapeutic bacteriostatic levels in patients concurrently taking these anticonvulsant medications.
• Therapeutic drug monitoring of serum doxycycline concentrations is recommended when co-administered with known drug metabolism inducers to ensure efficacy.